Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lushang Freda Pharmaceutical is a leading Chinese manufacturer of pharmaceuticals and cosmetic ingredients. It has a strong presence in sodium hyaluronate production for medical devices and cosmetics as well as food additives like natamycin and nisin. The company’s pharmaceutical portfolio covers five major therapeutic areas with both chemical medicines and traditional Chinese patent medicines. Its subsidiaries further expand its reach into dietary supplements OEM/ODM services. No clinical trial results are reported.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lushang Freda Pharmaceutical.